Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Compugen Expands anti-PVRIG COM701 Intellectual Property Portfolio
      Health

      Compugen Expands anti-PVRIG COM701 Intellectual Property Portfolio

      August 10, 2022
      Trevena to Release Second Quarter 2022 Financial Results on August 11, 2022
      Health

      Trevena to Release Second Quarter 2022 Financial Results on August 11, 2022

      August 10, 2022
      Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
      Health

      Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates

      August 10, 2022
      Kintara Therapeutics Receives Study May Proceed Letter from the FDA for REM-001 for Cutaneous Metastatic Breast Cancer
      Health

      Kintara Therapeutics Receives Study May Proceed Letter from the FDA for REM-001 for Cutaneous Metastatic Breast Cancer

      August 10, 2022
      ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update
      Health

      ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update

      August 10, 2022
      Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform
      Health

      Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform

      August 10, 2022
      Tonix Pharmaceuticals to Present at the 2022 Virtual Q3 Investor Summit
      Health

      Tonix Pharmaceuticals to Present at the 2022 Virtual Q3 Investor Summit

      August 10, 2022
      Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier
      Health

      Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier

      August 10, 2022
      Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2022 and Reiterates Key Anticipated Near-Term Milestones
      Health

      Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2022 and Reiterates Key Anticipated Near-Term Milestones

      August 10, 2022
      Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
      Health

      Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering

      August 10, 2022
      « 1 … 234 235 236 237 238 … 247 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026